+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Polyarticular Juvenile Idiopathic Arthritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768231
  • Report
  • 56 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • medac GmbH
  • MORE
The global clinical trial report- “2019 Polyarticular Juvenile Idiopathic Arthritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Polyarticular Juvenile Idiopathic Arthritis. It presents in-depth analysis of Polyarticular Juvenile Idiopathic Arthritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Polyarticular Juvenile Idiopathic Arthritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Polyarticular Juvenile Idiopathic Arthritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Polyarticular Juvenile Idiopathic Arthritis

The research work is prepared through extensive and continuous research on Polyarticular Juvenile Idiopathic Arthritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Polyarticular Juvenile Idiopathic Arthritis patients are identified
  • The report includes panorama of Polyarticular Juvenile Idiopathic Arthritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Polyarticular Juvenile Idiopathic Arthritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • medac GmbH
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Polyarticular Juvenile Idiopathic Arthritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Region
2.2.2 Average Enrollment of Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Polyarticular Juvenile Idiopathic Arthritis Treatment, 2019

3. Region wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
3.1 Asia Pacific Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Country
3.2 Europe Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Country
3.3 North America Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Country
3.4 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Country
3.5 South and Central America Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Country

4. Polyarticular Juvenile Idiopathic Arthritis Clinical Trial Trends
4.1 Start Year wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
4.2 Phase wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
4.3 Trial Status wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
4.4 Trial Type wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials

5. Polyarticular Juvenile Idiopathic Arthritis Average Enrollment Trends
5.1 Average Enrollment in Polyarticular Juvenile Idiopathic Arthritis Trials by Year
5.2 Average Enrollment in Polyarticular Juvenile Idiopathic Arthritis Trials by Phase
5.3 Average Enrollment in Polyarticular Juvenile Idiopathic Arthritis Trials by Status
5.4 Average Enrollment in Polyarticular Juvenile Idiopathic Arthritis Trials by Type of Trial

6. Companies Participating in Polyarticular Juvenile Idiopathic Arthritis Clinical Trials
6.1 Polyarticular Juvenile Idiopathic Arthritis Trials by Sponsor Type
6.2 Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Polyarticular Juvenile Idiopathic Arthritis Trials- Phase 1
7.2 Polyarticular Juvenile Idiopathic Arthritis Trials- Phase 2
7.3 Polyarticular Juvenile Idiopathic Arthritis Trials- Phase 3
7.4 Polyarticular Juvenile Idiopathic Arthritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Figure 9: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Phase
Figure 10: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Trial Status
Figure 11: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Type
Figure 12: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Sponsor Type
Figure 13: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials by Leading Sponsors
Figure 14: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Phase
Figure 15: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Trial Status
Figure 16: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Type
Figure 17: Polyarticular Juvenile Idiopathic Arthritis- Average Enrolment by Type of Sponsors
Figure 18: Polyarticular Juvenile Idiopathic Arthritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Polyarticular Juvenile Idiopathic Arthritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Table 7: North America - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Polyarticular Juvenile Idiopathic Arthritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Phase
Table 15: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Trial Status
Table 16: Polyarticular Juvenile Idiopathic Arthritis Average Enrollment by Type
Table 17: Polyarticular Juvenile Idiopathic Arthritis- Average Enrolment by Type of Sponsors
Table 18: Polyarticular Juvenile Idiopathic Arthritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • C. H. Boehringer Sohn AG & Co KG
  • Coherus BioSciences Inc
  • F. Hoffmann-La Roche Ltd
  • medac GmbH
  • Novartis AG
  • Pfizer Inc
  • PTC Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768231
Adroll
adroll